Sex hormone-binding globulin and risk of clinical diabetes in American black, Hispanic, andAsian/Pacific islander postmenopausal women

Clinical Chemistry

Volumn 58, Issue 10, 2012, Pages 1457-1466

  Chen, Brian H ^a,b   Brennan, Kathleen ^a,b,c   Goto, Atsushi ^a,b,d   Song, Yiqing ^e   Aziz, Najib ^c   You, Nai Chieh Y ^a,b   Wellons, Melissa F ^f   Manson, JoAnn E ^e   White, Donna L ^g   Butch, Anthony W ^c   Liu, Simin ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ESTRADIOL; HIGH SENSITIVITY C REACTIVE PROTEIN; INSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNIC GROUP; ETHNICITY; FEMALE; FOLLOW UP; HISPANIC; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RISK FACTOR; TESTOSTERONE BLOOD LEVEL;

AFRICAN AMERICANS; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HISPANIC AMERICANS; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; OCEANIC ANCESTRY GROUP; OVERWEIGHT; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; UNITED STATES;

EID: 84866972043     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.193086     Document Type: Article

References (33)

1. Rosner W, Deakins SM. Testosterone-binding globulins in human plasma: studies on sex distribution and specificity. J Clin Invest 1968;47:2109-16.
2. Hammond GL, Bocchinfuso WP. Sex hormonebinding globulin: gene organization and structure/function analyses. Horm Res 1996;45:197-201. (Pubitemid 26079708)
3. Hammond GL, Underhill DA, Smith CL, Goping IS, Harley MJ, Musto NA, et al. The cDNA-deduced primary structure of human sex hormone-binding globulin and location of its steroid-binding domain. FEBS Lett 1987;215:100-4. (Pubitemid 17099146)
4. Hammes A, Andreassen TK, Spoelgen R, Raila J, Hubner N, Schulz H, et al. Role of endocytosis in cellular uptake of sex steroids. Cell 2005;122:751-62. (Pubitemid 41242639)
5. Rosner W, Hryb DJ, Kahn SM, Nakhla AM, Romas NA. Interactions of sex hormone-binding globulin with target cells. Mol Cell Endocrinol 2010;316:79-85.
6. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006;295:1288-99.
7. Lindstedt G, Lundberg PA, Lapidus L, Lundgren H, Bengtsson C, Bjorntorp P. Low sex-hormonebinding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes 1991;40:123-8.
8. Haffner SM, Valdez RA, Morales PA, Hazuda HP, Stern MP. Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab 1993;77:56-60. (Pubitemid 23206776)
9. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009;361:1152-63.
10. Perry JR, Weedon MN, Langenberg C, Jackson AU, Lyssenko V, Sparso T, et al. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet 2010;19:535-44.
11. Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, et al. Implementation of the women's health initiative study design. Ann Epidemiol 2003;13:S5-17.
12. Design of the Women's Health Initiative Clinical Trial and Observational Study. The Women's Health Initiative Study Group. Control Clin Trials 1998;19:61-109.
13. Margolis KL, Lihong Q, Brzyski R, Bonds DE, Howard BV, Kempainen S, et al. Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials 2008;5:240-7.
14. Song Y, Manson JE, Tinker L, Howard BV, Kuller LH, Nathan L, et al. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: The Women's Health Initiative Observational Study. Diabetes Care 2007;30:1747-52. (Pubitemid 47036347)
15. Liu S, Tinker L, Song Y, Rifai N, Bonds DE, Cook NR, et al. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 2007;167:1676-85. (Pubitemid 47280350)
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9. (Pubitemid 15018832)
17. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72. (Pubitemid 30645223)
18. Sodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801-10. (Pubitemid 13228095)
19. Endogenous Hormones and Breast Cancer Collaborative Group. Free estradiol and breast cancer risk in postmenopausal women: Comparison of measured and calculated values. Cancer Epidemiol Biomarkers Prev 2003;12:1457-61.
20. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 2004;89:525-33. (Pubitemid 38269853)
21. Rinaldi S, Geay A, Dechaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 2002;11:1065-71. (Pubitemid 35192658)
22. Okubo M, Tokui M, Egusa G, Yamakido M. Association of sex hormone-binding globulin and insulin resistance among Japanese-American subjects. Diabetes Res Clin Pract 2000;47:71-5.
23. Kalyani RR, Franco M, Dobs AS, Ouyang P, Vaidya D, Bertoni A, et al. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab 2009;94:4127-35.
24. Edmunds SE, Stubbs AP, Santos AA, Wilkinson ML. Estrogen and androgen regulation of sex hormone binding globulin secretion by a human liver cell line. J Steroid Biochem Mol Biol 1990;37:733-9.
25. O'Malley BW, Schrader WT, Mani S, Smith C, Weigel NL, Conneely OM, Clark JH. An alternative ligand-independent pathway for activation of steroid receptors. Recent Prog Horm Res 1995;50:333-47.
26. Porto CS, Lazari MF, Abreu LC, Bardin CW, Gunsalus GL. Receptors for androgen-binding proteins: internalization and intracellular signalling. J Steroid Biochem Mol Biol 1995;53:561-5.
27. Hryb DJ, Khan MS, Romas NA, Rosner W. Solubilization and partial characterization of the sex hormone-binding globulin receptor from human prostate. J Biol Chem 1989;264:5378-83. (Pubitemid 19097988)
28. Hryb DJ, Khan MS, Romas NA, Rosner W. The control of the interaction of sex hormone-binding globulin with its receptor by steroid hormones. J Biol Chem 1990;265:6048-54.
29. Nakhla AM, Khan MS, Rosner W. Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3′,5′-monophosphate. J Clin Endocrinol Metab 1990;71:398-404.
30. Frairia R, Fortunati N, Berta L, Fazzari A, Fissore F, Gaidano G. Sex steroid binding protein (SBP) receptors in estrogen sensitive tissues. J Steroid Biochem Mol Biol 1991;40:805-12.
31. Krupenko SA, Krupenko NI, Danzo BJ. Interaction of sex hormone-binding globulin with plasma membranes from the rat epididymis and other tissues. J Steroid Biochem Mol Biol 1994;51:115-24. (Pubitemid 24340053)
32. Brambilla DJ, Matsumoto AM, Araujo AB, McKinlay JB. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab 2009;94:907-13.
33. Lewis JG, Mopert B, Shand BI, Doogue MP, Soule SG, Frampton CM, Elder PA. Plasma variation of corticosteroid-binding globulin and sex hormone-binding globulin. Horm Metab Res 2006;38:241-5. (Pubitemid 43845216)